These MNP/CTL cells could be magnetically guided to the solid tumors in mice for improved CTL infiltration and tumor killing, and further aided with PD-1 antibody release through acid-mediated MNPs, for a synergistically enhanced immuno-oncotherapy with minimal side effects (82). This evidence concerns the gene PDCD1 and neoplasm.